We are live on ! Find out more
EA

Endowment Advisers Portfolio holdings

AUM $49K
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113K
AUM Growth
–
Cap. Flow
+$113K
Cap. Flow %
99.92%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$113K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
1
Pacira BioSciences
PCRX
$1.04B
$113K 100%
+3,903
New +$113K

Similar funds

AIB
Allied Irish Banks Dublin 4, Ireland $1.13M AUM
GV3
Group VI 31 Fort Worth, Texas $1.55M AUM
EDH
Eric D. Hovde $3.56M AUM
SCM
Straus Capital Management New York $4.65M AUM
TCA
Troob Capital Advisors Rye Brook, New York $5.04M AUM
AIS
APG Investment Services Dj Heerlen, Netherlands $6.7M AUM
LMIE
Legg Mason International Equities London, United Kingdom $8.29M AUM
JCF
J. Christopher Flowers $10.7M AUM

Endowment Advisers's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Endowment Advisers, which disclosed 1 position worth $113K. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Pacira BioSciences: 3,903 shares worth $113K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Endowment Advisers's largest Q2 2013 buy was Pacira BioSciences: 3,903 shares worth $113K.
  • Endowment Advisers's ten largest holdings make up 100% of its $113K portfolio in Q2 2013.
  • Endowment Advisers disclosed 1 position in Q2 2013, its first 13F filing on record.

Based on Endowment Advisers's 13F filing for Q2 2013, filed 31 Jul 2013.